Zevra Therapeutics (ZVRA) Cash & Equivalents (2014 - 2026)
Zevra Therapeutics' Cash & Equivalents came in at $122.15 million for Q3 2026, up 124.4% from $54.44 million a year earlier but down 15.9% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Cash & Equivalents was $62.41 million, up 84.7% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 71.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $33.79 million in FY2024 (-21.5%), $43.05 million in FY2023 (-34.2%), $65.47 million in FY2022 (-41.7%) and $112.35 million in FY2021.
- The five-year range for quarterly Cash & Equivalents is $33.79 million (Q4 2024) to $145.32 million (Q2 2026).
- Year-over-year, Cash & Equivalents has increased for six consecutive quarters, with growth averaging 69.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2026 (growth of 204.6%), and the weakest in Q1 2023 (a decline of 59.9%).
- Business Quant data shows ZVRA's Cash & Equivalents at $145.32 million (Q2 2026), $95.6 million (Q1 2026) and $62.41 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 122.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 122.15 Mn |
| Jun 30, 2026 | 145.32 Mn |
| Mar 31, 2026 | 95.60 Mn |
| Dec 31, 2025 | 62.41 Mn |
| Sep 30, 2025 | 54.44 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Mar 31, 2025 | 37.34 Mn |
| Dec 31, 2024 | 33.79 Mn |
| Sep 30, 2024 | 54.04 Mn |
| Jun 30, 2024 | 39.26 Mn |
| Mar 31, 2024 | 42.85 Mn |
| Dec 31, 2023 | 43.05 Mn |
| Sep 30, 2023 | 43.27 Mn |
| Jun 30, 2023 | 66.20 Mn |
| Mar 31, 2023 | 40.18 Mn |
| Dec 31, 2022 | 65.47 Mn |
| Sep 30, 2022 | 70.06 Mn |
| Jun 30, 2022 | 76.78 Mn |
| Mar 31, 2022 | 100.24 Mn |
| Dec 31, 2021 | 112.35 Mn |
API Access
Zevra Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();